Breaking News

Countrywide's Mozilo Said to Face U.S. Suit Over Subprime Loans
Tweet TWEET

Alere Inc. Schedules Conference Call for 8:30 a.m. ET May 9, 2013 to Discuss First Quarter 2013 Results

 Alere Inc. Schedules Conference Call for 8:30 a.m. ET May 9, 2013 to Discuss
                          First Quarter 2013 Results

PR Newswire

WALTHAM, Mass., May 2, 2013

WALTHAM, Mass., May 2, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global
leader in enabling individuals to take charge of their health at home through
the merger of rapid diagnostics and health information solutions, today
announced that it will release its first quarter 2013 earnings on Thursday,
May 9, 2013. The Company will also host a conference call beginning at 8:30
a.m. (Eastern Time) on that date to discuss these results and other corporate
matters. During the conference call, the Company will discuss and answer
questions concerning business and financial developments and trends. The
Company's responses to questions, as well as other matters discussed during
the conference call, may contain or constitute information that has not been
disclosed previously.

The conference call may be accessed by dialing (877) 270-2148 (domestic) or
(412) 902-6510 (international) and asking for Alere Inc. A webcast of the
call can also be accessed via the Alere website at www.alere.com/investors, or
directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately one hour after the conclusion of the
call and will remain available for a period of seven days following the call.
The replay may be accessed by dialing (877) 344-7529 (domestic) or (412)
317-0088 (international) and entering replay code 10028513. The replay will
also be available via online webcast at http://www.videonewswire.com/event or
via the Alere website at www.alere.com/investors for a period of 60 days
following the call.

By developing new capabilities in near-patient diagnosis, monitoring and
health information solutions, Alere enables individuals to take charge of
improving their health and quality of life at home. Alere's global leading
products and services, as well as its new product development efforts, focus
on cardiology, infectious disease, toxicology and diabetes. Alere is
headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.



SOURCE Alere Inc.

Website: http://www.alere.com
Contact: Doug Guarino, 781-647-3900
 
Press spacebar to pause and continue. Press esc to stop.